Brief: Atara Biotherapeutics CFO To Step Down
08/02/2023 23:25
Feb 8 (Reuters) - Atara Biotherapeutics Inc ATRA.O :
* ON FEB 3, UTPAL KOPPIKAR, EXECUTIVE VICE PRESIDENT, CFO,
NOTIFIED CO OF HIS INTENTION TO RESIGN, EFFECTIVE MARCH 31, 2023
* ON FEB 3, CO APPOINTED ERIC HYLLENGREN TO SERVE AS SENIOR
VICE
PRESIDENT, CFO, EFFECTIVE AS OF APRIL 1, 2023
Further company coverage: ATRA.O
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing